Literature DB >> 2550210

A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.

S Monno1, N Takasu.   

Abstract

We present a report on two sisters who have 17 alpha-hydroxylase deficiency with hyperaldosteronism. They have hypertension and hypergonadotropic hypogonadism. The steroid profiles suggest that they have 17 alpha-hydroxylase deficiency. In contrast to the classical biochemical findings in 17 alpha-hydroxylase deficiency, both of these patients have hyperaldosteronism. Thus this report describes a new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism. Dexamethasone suppressed the mineralocorticoid excess, including aldosterone, and improved their hypertension. In the untreated state, ACTH, instead of the renin-angiotensin system, regulated plasma aldosterone levels, but during dexamethasone treatment the renin-angiotensin system regulated these levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550210     DOI: 10.1507/endocrj1954.36.315

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

1.  17 alpha-Hydroxylase deficiency with persistence of müllerian ducts in a genotypic male and paradoxical aldosterone secretion.

Authors:  N S Panesar; V T Yeung; J C Chan; C C Shek; M G Nicholls; C S Cockram
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 2.  Congenital adrenal hyperplasia causing hypertension: an illustrative review.

Authors:  Laura Hinz; Daniele Pacaud; Gregory Kline
Journal:  J Hum Hypertens       Date:  2017-12-18       Impact factor: 3.012

3.  Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease.

Authors:  N Takasu; N Ohara; T Yamada; I Komiya
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.